Cargando…
Serum osteoprotegerin levels are related to height loss: The Tromsø Study
Severe loss of body height is often a consequence of osteoporotic vertebral fractures. Osteoprotegerin (OPG) and receptor activator of nuclear factor-kB ligand (RANKL) are cytokines essential for the regulation of bone resorption. The aim of this study was to assess the relationship between the OPG/...
Autores principales: | Jørgensen, Lone, Hansen, John-Bjarne, Brox, Jan, Mathiesen, Ellisiv, Vik, Anders, Jacobsen, Bjarne K. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3088831/ https://www.ncbi.nlm.nih.gov/pubmed/21331661 http://dx.doi.org/10.1007/s10654-011-9555-8 |
Ejemplares similares
-
Serum osteoprotegerin and renal function in the general population: the Tromsø Study
por: Vik, Anders, et al.
Publicado: (2017) -
Thoracolumbar vertebral fractures in Sweden: an analysis of 13,496 patients admitted to hospital
por: Jansson, Karl-Åke, et al.
Publicado: (2010) -
Cohort profile: The Tromsø Study
por: Jacobsen, Bjarne K, et al.
Publicado: (2012) -
Fish consumption, fish oil supplements and risk of atherosclerosis in the Tromsø study
por: Johnsen, Stein Harald, et al.
Publicado: (2018) -
Atherosclerotic Risk Factors and Risk of Myocardial Infarction and Venous Thromboembolism; Time-Fixed versus Time-Varying Analyses. The Tromsø Study
por: Småbrekke, Birgit, et al.
Publicado: (2016)